重组抗荧光素单抗(4-4-20 (enhanced)),小鼠IgG3 Kappa | Syd Labs PA007702.m3
Syd Labs体内实验级重组抗荧光素(Anti-Fluorescein / Anti-FITC)单克隆抗体,克隆号 4-4-20(enhanced,亲和力增强版),恒定区为小鼠 IgG3 Kappa(Mouse IgG3 Kappa),由哺乳动物细胞重组表达,序列明确、无杂交瘤遗传漂变风险、无腹水内源抗体污染,特异性识别荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及FITC-蛋白/多糖/核酸/葡聚糖偶联物具有亚纳摩尔级高亲和力(K_d ~ 10⁻¹⁰ M)。小鼠 IgG3 是四大小鼠IgG亚类中功能最特殊的T细胞非依赖(TI)型抗体,核心特性:①补体激活/CDC活性为各亚类最强——短铰链区(仅11个氨基酸)使Fc段间距短、C1q结合构象最优,补体经典途径激活效率显著高于IgG2a/2b/2c,介导超强补体依赖调理吞噬和溶菌效应;②无ADCC/ADCP活性——CH2结构域不结合任何激活性FcγR(FcγRI/III/IV),不桥接NK细胞、巨噬细胞介导细胞毒,所有效应功能完全依赖补体系统;③多价抗原凝集/沉淀效率最优——Fc段CH3结构域存在同源Fc-Fc相互作用界面,抗体可自组装为可逆性二聚/寡聚体;结合多糖、多聚体、病毒颗粒等含重复表位的多价抗原时,Fab交联+Fc自聚协同形成大免疫复合物,凝集反应、免疫沉淀、免疫双扩散灵敏度为各亚类最高,是经典的”凝集型抗体”;④T细胞非依赖(TI)应答标志亚类——由细菌荚膜多糖、LPS、Ficoll、葡聚糖等TI-2抗原诱导,是抗胞外荚膜菌(肺炎链球菌、流感嗜血杆菌、沙门氏菌)感染的主要保护性抗体亚类;⑤纯化特性:不结合Protein A,弱至中等结合Protein G,纯化首选Protein G或抗原亲和柱;⑥所有小鼠品系通用——编码IgG3的Igh-4基因座在BALB/c、C57BL/6、NOD、SJL等所有常用品系中保守表达,无IgG2a/2c的同种异型限制,体内注射无抗抗体反应;⑦冷沉淀特性:4℃低温下Fc-Fc自聚会加剧,出现可逆性冷沉淀,37℃温育5-10分钟即可复溶,不影响活性。荧光素(Fluorescein)又称 FITC(异硫氰酸荧光素)、FAM(6-羧基荧光素)、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350,是呫吨类绿色荧光染料(Ex≈494 nm/Em≈521 nm)。小鼠IgG3版本特别适用于:①FITC标记多糖/多聚体/颗粒抗原的凝集/沉淀实验(核心用途);②补体激活机制研究、CDC实验最强阳性对照;③T细胞非依赖抗多糖免疫应答研究;④侧向流金标/荧光微球偶联(多价结合灵敏度高);⑤小鼠体内补体依赖调理吞噬实验;⑥所有品系小鼠IgG3同型对照。本品经Protein G亲和纯化,还原性SDS-PAGE及HPLC检测纯度>95%,0.2 μM过滤于1×PBS溶液,适用于凝集/沉淀实验、CDC功能实验、WB、ELISA、流式、IHC/IF及侧向流检测。
产品参数
| 货号 | PA007702.m3 |
|---|---|
| 产品名称 | 重组抗荧光素单抗(4-4-20 (enhanced)),小鼠IgG3 Kappa | Syd Labs PA007702.m3 |
| 英文名 | Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Mouse IgG3 Kappa |
| 供货商名称 | Syd Labs, Inc. |
| 品牌名 | Syd Labs |
| 别称 | Fluorescein、FITC(Fluorescein isothiocyanate / 异硫氰酸荧光素 / 荧光素异硫氰酸酯)、FAM(6-Carboxyfluorescein / 6-羧基荧光素)、Fluorescein isomer I、Resorcinolphthalein、Uranine(荧光素钠)、C.I. 45350、D&C Yellow No.7 |
| 克隆号 | 4-4-20 (enhanced) |
| 同种型 | 小鼠IgG3 Kappa |
| 特异性 | 特异性结合荧光素(Fluorescein/FITC/FAM)核心呫吨环结构,对游离荧光素及 FITC-蛋白/抗体/葡聚糖/核酸偶联物均有高亲和力 |
| 抗体形式 | 0.2 μM 过滤的 1× PBS 溶液 |
| 纯度 | 还原性条件下 SDS-PAGE 及 HPLC 检测>95% |
| 运输 | 采用冰袋运输;收到后请立即按下方推荐温度保存 |
| 稳定性与存储 | 使用手动除霜冰箱,避免反复冻融;自收货之日起12个月,按供货状态于−20 ℃至−70 ℃保存;自收货之日起1个月,按供货状态于2 ℃至8 ℃保存 |
| 产品咨询 | Syd Labs在国内只通过代理商销售其产品,不做直销。终端用户咨询价格请联系Syd Labs中国代理商。 关于Syd Labs产品如果有任何技术或其它问题,欢迎随时联系Syd Labs国内市场推广合作伙伴:武汉多找找科技有限公司,企业微信:duozhaozhao2024 联系电话:18162581039(龙经理) |
| 应用详情 | 补体激活/CDC功能实验(最强阳性对照)、FITC标记多糖/多聚体/颗粒抗原的凝集/沉淀/免疫双扩散实验(核心用途)、T细胞非依赖(TI)抗多糖免疫应答研究、侧向流免疫层析试纸(LFT/LFD,金标/荧光微球多价偶联灵敏度高)、Western Blot、ELISA、IHC/IF、流式细胞术、小鼠体内补体依赖调理吞噬实验、所有品系小鼠IgG3同型对照 |
文献
PA007702.m3: Syd Labs 重组抗荧光素单克隆抗体(克隆号4-4-20 (enhanced)) ,小鼠IgG3 Kappa(Recombinant Anti-Fluorescein Monoclonal Antibody (Clone: 4-4-20 (enhanced)), Mouse IgG3 Kappa)
重组抗荧光素单抗(4-4-20 (enhanced))背景知识:
我们的重组抗荧光素抗体(克隆号 4-4-20 增强型)为序列明确、哺乳动物细胞表达的抗 FITC 单克隆抗体,可特异性识别结合在蛋白、多肽、核酸或固相基质上的荧光素母核结构。该重组抗荧光素半抗原抗体稳定性高、性能可靠,是识别荧光素标记靶标、在各类常规体外免疫检测中放大信号的关键二步检测试剂,可彻底规避杂交瘤细胞株遗传漂移带来的风险。
相较于传统生物素 – 链霉亲和素体系,荧光素 / 抗荧光素检测体系具备突出优势:生物素广泛存在于多种哺乳动物组织及细胞裂解液中,因此基于生物素的检测往往背景偏高、易出现假阳性;而生物样本中天然不含荧光素,使用这款重组抗 FITC 单克隆抗体能够完全消除内源背景干扰。因此,该抗荧光素半抗原抗体非常适合用于复杂样本的体外诊断、ELISA 以及高通量筛选平台,可获得低背景、高准确度的实验数据。
我们可针对 4-4-20 增强型骨架提供全套抗体定制改造与规模化生产服务,面向诊断试剂盒研发企业及科研实验室。可提供的定制类型包括:
亚型转换与 Fc 改造:多种重链 / 轻链亚型以及改造型 Fc 变体(如效应沉默 LALAPG 突变体);
亲和标签:可重组添加 Avi 标签、His 标签或 DYKDDDDK(FLAG)标签,适配特定实验取向;
标记偶联:生物素化版本,也可直接偶联多种荧光基团、染料以及酶(辣根过氧化物酶 HRP、碱性磷酸酶 AP)。
重组抗荧光素单抗(4-4-20 (enhanced))部分参考文献:
1. CRISPR/Cas12a and fork-shaped probe enhance LAMP-LFT integration for equipment-free detection of Listeria monocytogenes.
Safenkova IV, et al.
Food Res Int. 2026 Apr;230:118592. PMID: 41794473 DOI: 10.1016/j.foodres.2026.118592
“An isothermal amplification assay integrated with lateral flow test (LFT) was developed for equipment-free detection of Listeria monocytogenes. In both LAMP-LFT and LAMP-CRISPR/Cas12a-LFT formats, fluorescein- and biotin-labeled amplicons were detected using a common conjugate of gold nanoparticles and anti-fluorescein (anti-FAM) antibodies, with a cleaved fork-shaped multi-fluorescein probe enabling visual readout on strips coated with anti-FAM capture antibody. The optimized assay achieved a single-cell detection limit (0.2 cells/reaction in buffer, 1 cell/reaction in spiked milk) within 80 min.”
2.A Versatile Cytochemical Labeling Technique as a Forensic Decision-Support Tool for In Situ Detection of Cell-Derived Markers in Invisible Biological Traces.
Bastat M, et al.
Anal Chem. 2025 Oct;97(41):22497–22507. PMID: 41057037 DOI: 10.1021/acs.analchem.5c02284
“A dual chromogenic and fluorescent in situ cytochemistry tool was developed to highlight invisible touch-DNA traces (e.g., fingermark corneocytes) on crime-scene surfaces. Chromogenic labeling of mannose residues and keratin 10 allowed visualization of as few as 100 shed cells, while a combination of FITC-conjugated primary probes and an HRP-conjugated anti-FITC antibody enabled simultaneous chromogenic and fluorescent detection across light and opaque substrates (ceramic, metal), supporting on-field sampling decisions prior to DNA extraction.”
3.Development of Reverse Transcriptase Recombinase Polymerase Amplification Combined with Lateral Flow Dipstick for Rapid Detection of Tilapia Lake Virus (TiLV): Pilot Study.
Srivorakul S, et al.
Vet Sci. 2025 Sep;12(9):845. PMID: 41012770 DOI: 10.3390/vetsci12090845
“A reverse-transcriptase recombinase polymerase amplification assay combined with a lateral flow dipstick (RT-RPA-LFD) was developed for point-of-care detection of Tilapia Lake Virus. The dipstick was prepared with immobilized anti-FITC and anti-biotin capture antibodies compatible with TiLV-specific primers tagged with FITC and biotin. Reverse transcription and RPA amplification were completed at 39 °C within 20 min, and products were visualized as a positive band on the LFD, achieving a 3.19 copies/µL limit of detection—a 100-fold improvement over RT-PCR-LFD.”
4.Identification, sorting and profiling of functional killer cells via the capture of fluorescent target-cell lysate.
Luah YH, et al.
Nat Biomed Eng. 2024 Mar;8(3):248–262. PMID: 37652987 DOI: 10.1038/s41551-023-01089-z
“PAINTKiller, a flow-cytometry-compatible assay for identifying and sorting functional cytotoxic effector cells in co-cultures, relies on capturing the intracellular carboxyfluorescein succinimidyl ester released from lysed target cells onto the surface of the killing lymphocyte. Capture was achieved using a bispecific complex consisting of an anti-fluorescein isothiocyanate antibody linked to an antibody against the pan-leucocyte receptor CD45, which ‘painted’ the natural killer cell surface with fluorescent lysate and enabled FACS sorting followed by single-cell RNA-seq profiling of killer-cell subpopulations.”
5.Fluorescein-switching-based lateral flow assay for the detection of microRNAs.
Ryu JY, et al.
Org Biomol Chem. 2024 Oct;22(40):8182–8188. PMID: 39291769 DOI: 10.1039/d4ob01311e
“A fluorescein-switching lateral flow assay was developed for naked-eye detection of microRNA biomarkers (miR-6090 and miR-141 for prostate cancer). Reduced fluorescein on the probe only weakly binds gold-nanoparticle-conjugated anti-fluorescein antibodies; in the presence of target microRNA, riboflavin tetraacetate photo-oxidizes the probe back to native fluorescein, which strongly binds the antibodies on the strip to produce a visible line. Sodium borohydride was introduced to minimize background, enabling fmol-level microRNA detection with minimal false positives for point-of-care cancer diagnostics.”




